| Undifferentiated Sarcoma studied in …STUDIED_INderived58 of 58show fewer |
|---|
| → studied in | NCT02923778Phase 2 · active not recruiting Talimogene Laherparepvec and Radiation Therapy in Treating Patients With Newly Diagnosed Soft Tissue Sarcoma That Can Be Removed by Surgery · condition mapped ONTOLOGY_EXACT · 58 trials mapped (25 active) | — | — | Undifferentiated Pleomorphic Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06422806Phase 3 · recruiting Measuring if Immunotherapy Plus Chemotherapy is Better Than Chemotherapy Alone for Patients With Aggressive Poorly Differentiated Sarcomas · condition mapped CURATED_BROADER · 58 trials mapped (25 active) | — | — | Undifferentiated Pleomorphic Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07823491Phase 3 · not yet recruiting Pembrolizumab and Radiation Therapy With or Without Neoadjuvant Doxorubicin and Ifosfamide for the Treatment of High-Risk Resectable Undifferentiated Pleomorphic Sarcoma or Liposarcoma of the Extremity or Trunk Wall · condition mapped CURATED_BROADER · 58 trials mapped (25 active) | — | — | Undifferentiated Pleomorphic Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07802652Phase 2 · not yet recruiting Doxorubicin With or Without DT-7012 in Advanced Soft Tissue Sarcoma · condition mapped ONTOLOGY_EXACT · 58 trials mapped (25 active) | — | — | Undifferentiated Pleomorphic Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03307616Phase 2 · active not recruiting Nivolumab With and Without Ipilimumab and Radiation Therapy in Treating Patients With Recurrent or Resectable Undifferentiated Pleomorphic Sarcoma or Dedifferentiated Liposarcoma Before Surgery · condition mapped CURATED_BROADER · 58 trials mapped (25 active) | — | — | Undifferentiated Pleomorphic Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07817095Phase 2 · not yet recruiting SBRT Combined With Reduced-Dose Anthracycline Chemotherapy and Toripalimab as Neoadjuvant Therapy for Localized High-Risk Undifferentiated Pleomorphic Sarcoma · condition mapped ONTOLOGY_EXACT · 58 trials mapped (25 active) | — | — | Undifferentiated Pleomorphic Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05711615Phase 1 · recruiting Testing Low-Dose Common Chemotherapy (Liposomal Doxorubicin) in Combination With an Anti-Cancer Drug, Peposertib, in Advanced Sarcoma · condition mapped CURATED_BROADER · 58 trials mapped (25 active) | — | — | Undifferentiated Pleomorphic Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05918640Phase 1/Phase 2 · recruiting Lurbinectedin in FET-Fused Tumors · condition mapped CURATED_BROADER · 58 trials mapped (25 active) | — | — | Undifferentiated Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06820957Phase 2/Phase 3 · active not recruiting Testing a New Combination of Anti-cancer Drugs in Patients Newly Diagnosed With Ewing Sarcoma Who Have Cancer That Has Spread to Other Parts of the Body · condition mapped CURATED_BROADER · 58 trials mapped (25 active) | — | — | Undifferentiated Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05827614Phase 1 · terminated Study of the CHK1 Inhibitor BBI-355, an ecDNA-directed Therapy (ecDTx), and the RNR Inhibitor BBI-825, in Subjects With Tumors With Oncogene Amplifications · condition mapped ONTOLOGY_EXACT · 58 trials mapped (25 active) | — | — | Undifferentiated Pleomorphic Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06239272Phase 1/Phase 2 · recruiting NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS) · condition mapped CURATED_BROADER · 58 trials mapped (25 active) | — | — | Undifferentiated Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07741877Phase 2 · not yet recruiting A Study of Lifileucel (Tumor-infiltrating Lymphocytes) in Adults With Advanced Soft Tissue Sarcoma · condition mapped ONTOLOGY_EXACT · 58 trials mapped (25 active) | — | — | Undifferentiated Pleomorphic Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06789172Phase 1 · recruiting A Phase 1, First-in-human Study of OKN4395 and Pembrolizumab in Patients With Solid Tumors · condition mapped ONTOLOGY_EXACT · 58 trials mapped (25 active) | — | — | Undifferentiated Pleomorphic Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04123535NA · terminated Focused Ultrasound to Promote Immune Responses for Undifferentiated Pleomorphic Sarcoma · condition mapped ONTOLOGY_EXACT · 58 trials mapped (25 active) | — | — | Undifferentiated Pleomorphic Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04332874Phase 2 · recruiting A Study of Pembrolizumab Plus Local Chemotherapy Using Isolated Limb Infusion (ILI) for Patients With Sarcoma in the Arm or Leg · condition mapped ONTOLOGY_EXACT · 58 trials mapped (25 active) | — | — | Undifferentiated Pleomorphic Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05836571Phase 2 · active not recruiting Testing Ipilimumab and Nivolumab Combination With or Without Cabozantinib in People >= 18 Years Old With Advanced Soft Tissue Sarcoma · condition mapped CURATED_BROADER · 58 trials mapped (25 active) | — | — | Undifferentiated Pleomorphic Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04420975Phase 1 · active not recruiting Nivolumab and BO-112 Before Surgery for the Treatment of Resectable Soft Tissue Sarcoma · condition mapped CURATED_BROADER · 58 trials mapped (25 active) | — | — | Undifferentiated Pleomorphic Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04008238NA · completed Prospective Identification of Predictive Biomarkers of Trabectedin Efficacy in Non-L Soft-tissue Sarcoma Patients · condition mapped ONTOLOGY_EXACT · 58 trials mapped (25 active) | — | — | Undifferentiated Pleomorphic Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04055220NA · recruiting Efficacy and Safety of Regorafenib as Maintenance Therapy After First-line Treatment in Patients With Bone Sarcomas · condition mapped ONTOLOGY_EXACT · 58 trials mapped (25 active) | — | — | Undifferentiated Pleomorphic Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07169344Phase 2 · recruiting Hypofractionated, 3-week, Preoperative Proton or X-ray Radiotherapy for Patients With Localized Soft Tissue Sarcoma · condition mapped ONTOLOGY_EXACT · 58 trials mapped (25 active) | — | — | Undifferentiated Pleomorphic Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07173972Phase 2 · recruiting Dose-escalated, Hypofractionated, Definitive Proton Radiotherapy for Patients With Inoperable Soft Tissue Sarcoma. · condition mapped ONTOLOGY_EXACT · 58 trials mapped (25 active) | — | — | Undifferentiated Pleomorphic Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04995003Phase 1 · recruiting HER2 Chimeric Antigen Receptor (CAR) T Cells in Combination With Checkpoint Blockade in Patients With Advanced Sarcoma · condition mapped CURATED_BROADER · 58 trials mapped (25 active) | — | — | Undifferentiated Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05182164Phase 2 · recruiting Combination of Pembrolizumab and Cabozantinib in Patients With Advanced Sarcomas · condition mapped ONTOLOGY_EXACT · 58 trials mapped (25 active) | — | — | Undifferentiated Pleomorphic Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03425279Phase 1/Phase 2 · completed CAB-AXL-ADC Safety and Efficacy Study in Adult and Adolescent Patients With Sarcoma · condition mapped ONTOLOGY_EXACT · 58 trials mapped (25 active) | — | — | Undifferentiated Pleomorphic Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03899805Phase 2 · completed A Phase II Study of Eribulin and Pembrolizumab in Soft Tissue Sarcomas · condition mapped ONTOLOGY_EXACT · 58 trials mapped (25 active) | — | — | Undifferentiated Pleomorphic Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04242238Phase 1 · completed Study of DCC-3014 in Combination With Avelumab in Patients With Advanced or Metastatic Sarcomas · condition mapped ONTOLOGY_EXACT · 58 trials mapped (25 active) | — | — | Undifferentiated Pleomorphic Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06277154Phase 2 · recruiting MASCT-I Combined With Doxorubicin and Ifosfamide for First-line Treatment of Advanced Soft Tissue Sarcoma · condition mapped ONTOLOGY_EXACT · 58 trials mapped (25 active) | — | — | Undifferentiated Pleomorphic Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05357768recruiting Global collaboRAtion on CIC-DUX4, BCOR-CCN3, High-grade Undifferentiated Round Cell Sarcoma (URCS) Project · condition mapped ONTOLOGY_EXACT · 58 trials mapped (25 active) | — | — | Undifferentiated Round Cell Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03241745Phase 2 · completed A Study of Nivolumab in Selected Uterine Cancer Patients · condition mapped CURATED_BROADER · 58 trials mapped (25 active) | — | — | Undifferentiated Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05017103Phase 2 · terminated Sintilimab for the Treatment of Locally Advanced, Metastatic, Recurrent, or Unresectable Undifferentiated Pleomorphic Sarcoma, SiARa Cancer Study · condition mapped CURATED_BROADER · 58 trials mapped (25 active) | — | — | Undifferentiated Pleomorphic Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06526897NA · not yet recruiting Evaluation of Chest CT Versus Chest X-Ray for Lung Surveillance After Curative-Intent Resection of High-Risk Truncal-Extremity Soft Tissue Sarcoma · condition mapped ONTOLOGY_EXACT · 58 trials mapped (25 active) | — | — | Undifferentiated Pleomorphic Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06370871Phase 3 · withdrawn Brightline-3: A Study to Find Out Whether Brigimadlin in Combination With Ezabenlimab Helps People With Advanced Soft Tissue Sarcoma · condition mapped ONTOLOGY_EXACT · 58 trials mapped (25 active) | — | — | Undifferentiated Pleomorphic Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03752398Phase 1 · completed A Study of XmAb®23104 in Subjects With Selected Advanced Solid Tumors (DUET-3) · condition mapped ONTOLOGY_EXACT · 58 trials mapped (25 active) | — | — | Undifferentiated Pleomorphic Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04480502Phase 2 · unknown ENVASARC: Envafolimab And Envafolimab With Ipilimumab In Patients With Undifferentiated Pleomorphic Sarcoma Or Myxofibrosarcoma · condition mapped ONTOLOGY_EXACT · 58 trials mapped (25 active) | — | — | Undifferentiated Pleomorphic Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03670069Phase 1 · terminated Itacitinib in Treating Patients With Refractory Metastatic/Advanced Sarcomas · condition mapped CURATED_BROADER · 58 trials mapped (25 active) | — | — | Undifferentiated Pleomorphic Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02584309Phase 2 · completed Doxorubicin With Upfront Dexrazoxane for the Treatment of Advanced or Metastatic Soft Tissue Sarcoma · condition mapped ONTOLOGY_EXACT · 58 trials mapped (25 active) | — | — | Undifferentiated Pleomorphic Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02500797Phase 2 · completed Nivolumab With or Without Ipilimumab in Treating Patients With Metastatic Sarcoma That Cannot Be Removed by Surgery · condition mapped CURATED_BROADER · 58 trials mapped (25 active) | — | — | Undifferentiated Pleomorphic Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03009201Phase 1 · completed Ribociclib and Doxorubicin in Treating Patients With Metastatic or Advanced Soft Tissue Sarcomas That Cannot Be Removed by Surgery · condition mapped CURATED_BROADER · 58 trials mapped (25 active) | — | — | Undifferentiated Pleomorphic Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05961761Phase 2 · recruiting Propranolol and Pembrolizumab in Advanced Soft Tissue Sarcoma Patients · condition mapped ONTOLOGY_EXACT · 58 trials mapped (25 active) | — | — | Undifferentiated Pleomorphic Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05515068not yet recruiting Registry For Children, Adolescents And Adults With Osteosarcoma And Biologically Related Bone Sarcomas · condition mapped ONTOLOGY_EXACT · 58 trials mapped (25 active) | — | — | Undifferentiated Pleomorphic Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02601209Phase 1/Phase 2 · terminated Sapanisertib or Pazopanib Hydrochloride in Treating Patients With Locally Advanced or Metastatic Sarcoma · condition mapped CURATED_BROADER · 58 trials mapped (25 active) | — | — | Undifferentiated Pleomorphic Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00346164Phase 3 · completed Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue Sarcoma · condition mapped ALIAS · 58 trials mapped (25 active) | — | — | Adult Undifferentiated Pleomorphic Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05116800Phase 2 · withdrawn Phase 2 Study of 9-ING-41 With Chemotherapy in Sarcoma · condition mapped ONTOLOGY_EXACT · 58 trials mapped (25 active) | — | — | Undifferentiated Pleomorphic Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01532687Phase 2 · completed Gemcitabine With or Without Pazopanib in Treating Patients With Refractory Soft Tissue Sarcoma · condition mapped ONTOLOGY_EXACT · 58 trials mapped (25 active) | — | — | Adult Undifferentiated Pleomorphic Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04099277Phase 1 · terminated A Study of LY3435151 in Participants With Solid Tumors · condition mapped ONTOLOGY_EXACT · 58 trials mapped (25 active) | — | — | Undifferentiated Pleomorphic Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04906876Phase 2 · withdrawn A Phase 2 Study of 9-ING-41Combined With Chemotherapy in Adolescents and Adults With Advanced Sarcomas · condition mapped ONTOLOGY_EXACT · 58 trials mapped (25 active) | — | — | Undifferentiated Pleomorphic Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03989596Phase 2 · unknown Hypofractionated Radiotherapy With Hyperthermia in Unresectable or Marginally Resectable Soft Tissue Sarcomas · condition mapped ONTOLOGY_EXACT · 58 trials mapped (25 active) | — | — | Undifferentiated Pleomorphic Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03651375Phase 2 · unknown Hypofractionated Radiotherapy With Sequential Chemotherapy in Marginally Resectable Soft Tissue Sarcomas of Extremities or Trunk Wall · condition mapped CURATED_BROADER · 58 trials mapped (25 active) | — | — | Undifferentiated Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02310503completed Spanish Registry of Mohs Surgery · condition mapped ALIAS · 58 trials mapped (25 active) | — | — | Undifferentiated Pleomorphic Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03946943Phase 2 · unknown Study of Anlotinib Hydrochloride and Toripalimab in Subjects With Unresectable or Metastatic Undifferentiated Pleomorphic Sarcoma · condition mapped ONTOLOGY_EXACT · 58 trials mapped (25 active) | — | — | Undifferentiated Pleomorphic Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02565758Phase 1 · completed ABBV-085, an Antibody Drug Conjugate, in Subjects With Advanced Solid Tumors · condition mapped ONTOLOGY_EXACT · 58 trials mapped (25 active) | — | — | Undifferentiated Pleomorphic Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01154452Phase 1/Phase 2 · completed Vismodegib and Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Advanced or Metastatic Sarcoma · condition mapped ALIAS · 58 trials mapped (25 active) | — | — | Undifferentiated Pleomorphic Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00659360Phase 2 · completed AZD0530 in Treating Patients With Recurrent Locally Advanced or Metastatic Soft Tissue Sarcoma · condition mapped ALIAS · 58 trials mapped (25 active) | — | — | Adult Undifferentiated Pleomorphic Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01653028Phase 2 · completed Alisertib in Treating Patients With Advanced or Metastatic Sarcoma · condition mapped CURATED_BROADER · 58 trials mapped (25 active) | — | — | Undifferentiated Pleomorphic Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00112463Phase 2 · completed Depsipeptide (Romidepsin) in Treating Patients With Metastatic or Unresectable Soft Tissue Sarcoma · condition mapped ALIAS · 58 trials mapped (25 active) | — | — | Adult Undifferentiated Pleomorphic Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00503295Phase 2 · completed Safety and Efficacy Study of REOLYSIN® in the Treatment of Bone and Soft Tissue Sarcomas Metastatic to the Lung · condition mapped ALIAS · 58 trials mapped (25 active) | — | — | Undifferentiated Pleomorphic Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00245102Phase 2 · completed Sorafenib in Treating Patients With Metastatic, Locally Advanced, or Recurrent Sarcoma · condition mapped ALIAS · 58 trials mapped (25 active) | — | — | Adult Undifferentiated Pleomorphic Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00400569Phase 2 · completed Phase II Study of Sunitinib Malate for Metastatic and/or Surgically Unresectable Soft Tissue Sarcoma · condition mapped ALIAS · 58 trials mapped (25 active) | — | — | Undifferentiated Pleomorphic Sarcoma | 1 | Observed | clinicaltrials | graph → |